Top 10 Key Players companies in Imipenem by Highest Patent Value in the United States in 2022 – Discovery

Free Trial

The Imipenem top 10 is Discovery PatSnap’ annual ranking of the top 10 Highest Patent Value Imipenem Key Players in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

1	Bayer HealthCare Pharmaceuticals, Inc.	New Jersey, United States	Medicine,Cardiovascular agent,Clinical trial, ...[+2]	Avg patent value: 10.82 M
2	Merck & Co., Inc.	New Jersey, United States	Health care,Biopharmaceutical,Drug, ...[+2]	Avg patent value: 10.33 M
3	Merck Sharp & Dohme Corp.	New Jersey, United States	Prescription drug,Medicine,Stroke, ...[+2]	Avg patent value: 10.31 M
4	Marrone Bio Innovations, Inc.	California, United States	Pesticide,Biopesticide,Weed, ...[+2]	Avg patent value: 5.66 M
5	Codexis, Inc.	California, United States	Enzyme,Chemical engineering,Biocatalysis, ...[+2]	Avg patent value: 3.15 M
6	Hospira, Inc.	Illinois, United States	Medical equipment,Drug,Health care, ...[+2]	Avg patent value: 25,000
7	Pfizer Inc.	New York, United States	Health care,Clinical trial,Drug, ...[+2]	Avg patent value: 0
8	Procter & Gamble Co.	Ohio, United States	Toothpaste,Hair conditioner,SOAP, ...[+2]	Avg patent value: 0
9	XOMA Corp.	California, United States	Antibody,Software development,Medicine, ...[+2]	Avg patent value: 0
10	Genentech, Inc.	California, United States	Biotechnology,Biology,Medicine, ...[+2]	Avg patent value: 0